Colposcopy: Still useful in microbicide safety trials?

Sexually Transmitted Diseases

Volumn 39, Issue 6, 2012, Pages 465-469

  Mauck, Christine K ^a   Weiner, Debra H ^b   Lai, Jaim Jou ^b   Schwartz, Jill L ^a  

^a EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

^b FAMILY HEALTH INTERNATIONAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELLULOSE SULFATE; HYDROXYETHYLCELLULOSE; MICROBICIDE; N [4 CHLORO 3 (3 METHYL 2 BUTENYLOXY)PHENYL] 2 METHYL 3 FURANCARBOTHIOAMIDE; NONOXINOL 9; PLACEBO; POLYSTYRENESULFONIC ACID;

ADULT; ARTICLE; CLINICAL EXAMINATION; CLINICAL PRACTICE; COLPOSCOPY; CONTRACEPTIVE DEVICE; DRUG SAFETY; ECCHYMOSIS; EDEMA; ERYTHEMA; FEMALE; GEL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; MAJOR CLINICAL STUDY; PETECHIA; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); PRACTICE GUIDELINE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK ASSESSMENT; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASE; UTERINE CERVIX CANCER;

ADMINISTRATION, INTRAVAGINAL; ANTI-INFECTIVE AGENTS; COLPOSCOPY; DRUG RESISTANCE, VIRAL; FEMALE; GUIDELINES AS TOPIC; HIV INFECTIONS; HUMANS; MALE; NONOXYNOL; OBSERVER VARIATION; SURFACE-ACTIVE AGENTS; TREATMENT OUTCOME; VAGINA;

EID: 84861228773     PISSN: 01485717     EISSN: 15374521     Source Type: Journal    
DOI: 10.1097/OLQ.0b013e3182500f33     Document Type: Article

References (15)

1. CONRAD/WHO Manual for the Standardization of Colposcopy for the Evaluation of Vaginal Products, Update 2004. Geneva, Switzerland: CONRAD/WHO, 2004.
2. Ballagh SA, Mauck CK, Henry D, et al. A comparison of techniques to assess cervicovaginal irritation and evaluation of the variability between two observers. Contraception 2004; 70:241-249. (Pubitemid 39119987)
3. Van Damme L, Ramjee G, Alary M, et al; COL-1492 Study Group. Effectiveness of COL-1492, a nonoxynol-9 vaginal gel, on HIV-1 transmission in female sex workers: A randomised controlled trial. Lancet 2002; 360:971-977. (Pubitemid 35284107)
4. Mauck CK, Weiner DH, Lai J. Colposcopy: still useful in microbicide safety trials? Presented at: Microbicides 2010 conference; May 22-25, 2010; Pittsburgh, PA.
5. Schwartz JL, Ballagh SA, Creinin MD, et al. SILCS diaphragm: Postcoital testing of a new single-size contraceptive device. Contraception 2008; 78:237-244.
6. Schwartz JL, Kovalevsky G, Lai JJ, et al. A randomized six-day safety study of an antiretroviral microbicide candidate UC781, a non-nucleoside reverse transcriptase inhibitor. Sex Transm Dis 2008; 35:414-419. (Pubitemid 351440786)
7. Schwartz JL, Ballagh SA, Kwok C, et al. Fourteen-day safety and acceptability study of the universal placebo gel. Contraception 2007; 75:136-141. (Pubitemid 46108723)
8. Schwartz JL, Mauck C, Lai JJ, et al. Fourteen-day safety and acceptability study of 6% cellulose sulfate gel: A randomized double-blind Phase I safety study. Contraception 2006; 74:133-140. (Pubitemid 44062469)
9. von Mollendorf CE, Van Damme L, Moyes JA, et al. Results of a safety and feasibility study of the diaphragm used with ACIDFORM Gel or K-Y Jelly. Contraception 2010; 81:232-239.
10. Schwartz JL, Lai JJ, Creinin M, et al. Fourteen-day safety and acceptability study of ACIDFORM gel: A randomized Phase I safety study. Presented at: Microbicides 2006 conference; April 24-26 2006; Cape Town, South Africa.
11. Frew P, Parker K, Hixson B, et al. Assessment of a vaginal microbicide candidate and Phase I clinical trial experience among a diverse study cohort of southern US women. Presentation orally at: Microbicides 2010 conference; May 22-25, 2010; Pittsburgh, PA.
12. Whitehead SJ, Utaipiboon C, Thepamnuay S, et al. Safety and systemic absorption of topical UC781: Results from a Phase I randomized, placebo-controlled trial. Presented at: Microbicides 2010; May 22-25, 2010; Pittsburgh, PA.
13. Mauck CK, Doncel GF, Archer DF, et al. Assessing markers of inflammation after vaginal product use: Nonoxynol-9, cellulose sulfate, and HEC placebo comparative double-blind trial. Presented at: Microbicides 2010 conference; May 22-25, 2010; Pittsburgh, PA.
14. Abdool Karim SS, Richardson BA, Ramjee G, et al; on behalf of the HIV Prevention Trials Network (HPTN) 035 Study Team. Safety and effectiveness of BufferGel and 0.5% PRO2000 gel for the prevention of HIV infection in women. AIDS 2011; 25:957-966.
15. Abdool Karim Q, Abdool Karim SS, Frohlich JA, et al; CAPRISA 004 Trial Group. Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science 2010; 329:1168-1174.